Whether it is drug cost, conditions that require the payer to approve them, the patients health insurance plan, or the unaffordability of a plan that would cover weight loss, there are real-world barriers in our health care system, Shah said
Weeks three and four mark the stabilization phase
Ready to continue your journey
The patients most in need of intervention with weight-loss drugs are those who are experiencing weight-related comorbidities such as hypertension, type 2 diabetes or prediabetes, nonalcoholic fatty liver disease, polycystic ovary disease, infertility, osteoarthritis, and so forth
Peptide therapy harnesses the power of short chains of amino acids, known as peptides, to stimulate specific biological responses within the body
In a major clinical trial called STEP 8, researchers compared the two medications directly